A detailed history of American Portfolios Advisors transactions in Selecta Biosciences Inc stock. As of the latest transaction made, American Portfolios Advisors holds 7,250 shares of SELB stock, worth $6,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,250
Holding current value
$6,090
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$1.33 - $2.6 $9,642 - $18,850
7,250 New
7,250 $11.9 Million
Q3 2021

Mar 22, 2023

SELL
$3.36 - $4.62 $3,360 - $4,620
-1,000 Reduced 13.79%
6,250 $26 Million
Q2 2021

Mar 22, 2023

SELL
$2.82 - $5.01 $6,345 - $11,272
-2,250 Reduced 31.03%
5,000 $20.9 Million
Q1 2021

Mar 22, 2023

SELL
$2.92 - $5.07 $6,570 - $11,407
-2,250 Reduced 31.03%
5,000 $22.6 Million

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.